Generation of pig iPS cells: a model for cell therapy

Area of Science:

• Stem cell biology
• Regenerative medicine
• Large animal models

Background:

• Pig induced pluripotent stem cells (piPSCs) are crucial for preclinical cell therapy testing.
• Current piPSC generation methods are inefficient, relying on laborious viral transduction.

Purpose of the Study:

• To develop a simpler, more efficient method for generating piPSCs.
• To establish a foundation for large-scale, xeno-free, and integration-free piPSC production.

Main Methods:

• Single transfection of a polycistronic plasmid (Oct4, Sox2, Klf4, c-Myc, GFP) into pig ear fibroblasts.
• Utilized gelatin-coated plates, with or without feeder cells.
• Characterized derived piPSCs for pluripotency markers, karyotype stability, and teratoma formation.

Main Results:

• Achieved higher reprogramming efficiency and rate compared to retroviral methods.
• Successfully derived piPSCs expressing embryonic stem cell markers, with stable karyotypes.
• Demonstrated the ability to generate cardiomyocyte-like cells from piPSCs in vitro.

Conclusions:

• The developed method offers a simplified and efficient approach for piPSC generation.
• This technique facilitates the massive production of xeno-free and integration-free piPSCs.
• Provides a valuable tool for advancing iPSC technology in large animal models for preclinical applications.